(1) The board hereby approves the following drugs for the use in ocular treatment limited to the anterior segment of the eye and adnexa:

(a) anti-infective agents, including:

(i) antibiotic;

(ii) antiviral;

(iii) antifungal; and

(iv) antiparasitic;

(b) autoimmune agents, including:

(i) antiallergy;

(ii) antihistamines;

(iii) decongestants;

(iv) mast cell stabilizers; and

(v) antianaphylaxis;

(c) analgesics;

(d) anti-inflammatory agents;

(e) antiglaucoma agents;

(f) hyperosmotic agents;

(g) autonomic agents; and

(h) over the counter agents.